References
- Kantor ED, Rehm CD, Du M, White E, Giovannucci EL. Trends in dietary supplement use among US adults from 1999-2012. JAMA. 2016;316(14):1464–1474. doi:https://doi.org/10.1001/jama.2016.14403
- Chen F, Du M, Blumberg JB, Ho Chui KK, Ruan M, Rogers G, Shan Z, Zeng L, Zhang FF. Association among dietary supplement use, nutrient intake, and mortality among U.S. adults: a cohort study. Ann Intern Med. 2019;170(9):604–613. doi:https://doi.org/10.7326/M18-2478
- Bailey RL, Gahche JJ, Miller PE, Thomas PR, Dwyer JT. Why US adults use dietary supplements. JAMA Intern Med. 2013;173(5):355–361. doi:https://doi.org/10.1001/jamainternmed.2013.2299
- Sebastian RS, Cleveland LE, Goldman JD, Moshfegh AJ. Older adults who use vitamin/mineral supplements differ from nonusers in nutrient intake adequacy and dietary attitudes. J Am Diet Assoc. 2007;107(8):1322–1332. doi:https://doi.org/10.1016/j.jada.2007.05.010
- Tuna S, Dizdar O, Calis M. The prevalence of usage of herbal medicines among cancer patients. J BUON. 2013;18:1048–1051.
- Frenkel M, Ben-Arye E, Baldwin CD, Sierpina V. Approach to communicating with patients about the use of nutritional supplements in cancer care. South Med J. 2005;98(3):289–294. doi:https://doi.org/10.1097/01.SMJ.0000154776.71057.E8
- Vernieri C, Nichetti F, Raimondi A, Pusceddu S, Platania M, Berrino F, de Braud F. Diet and supplements in cancer prevention and treatment: clinical evidences and future perspectives. Crit Rev Oncol Hematol. 2018;123:57–73. doi:https://doi.org/10.1016/j.critrevonc.2018.01.002
- Abdel-Rahman O, Spratlin J, Koski S. Vitamin and herbal supplements' use among patients with advanced gastrointestinal cancers included in eight clinical trials. J Cancer Res Clin Oncol. 2020;146(8):2089–2097. doi:https://doi.org/10.1007/s00432-020-03201-1
- Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National Health and Nutrition Examination Survey Data. Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. https://www.cdc.gov/nchs/nhanes/index.htm [last accessed 01 May 2020].
- Austin PC. A comparison of 12 algorithms for matching on the propensity score. Stat Med. 2014;33(6):1057–1069. doi:https://doi.org/10.1002/sim.6004
- Mao JJ, Palmer CS, Healy KE, Desai K, Amsterdam J. Complementary and alternative medicine use among cancer survivors: a population-based study. J Cancer Surviv. 2011;5(1):8–17. doi:https://doi.org/10.1007/s11764-010-0153-7
- Shrank WH, Patrick AR, Brookhart MA. Healthy user and related biases in observational studies of preventive interventions: a primer for physicians. J Gen Intern Med. 2011;26(5):546–550. doi:https://doi.org/10.1007/s11606-010-1609-1
- Abdel-Rahman O. Outcomes of non-metastatic colon cancer patients in relationship to socioeconomic status: an analysis of SEER census tract-level socioeconomic database. Int J Clin Oncol. 2019;24(12):1582–1587. doi:https://doi.org/10.1007/s10147-019-01497-9
- Abdel-Rahman O. Treatment choices and outcomes of non-metastatic hepatocellular carcinoma patients in relationship to neighborhood socioeconomic status: a population-based study. Int J Clin Oncol. 2020;25(5):861–866. doi:https://doi.org/10.1007/s10147-020-01616-x
- Akutsu T, Kitamura H, Himeiwa S, Kitada S, Akasu T, Urashima M. Vitamin D and cancer survival: does vitamin D supplementation improve the survival of patients with cancer? Curr Oncol Rep. 2020;22(6):62. doi:https://doi.org/10.1007/s11912-020-00929-4
- Madden JM, Murphy L, Zgaga L, Bennett K. De novo vitamin D supplement use post-diagnosis is associated with breast cancer survival. Breast Cancer Res Treat. 2018;172(1):179–190. doi:https://doi.org/10.1007/s10549-018-4896-6
- Akiba T, Morikawa T, Odaka M, Nakada T, Kamiya N, Yamashita M, Yabe M, Inagaki T, Asano H, Mori S, et al. Vitamin D supplementation and survival of patients with non-small cell lung cancer: a randomized, double-blind, placebo-controlled trial. Clin Cancer Res. 2018;24(17):4089–4097. doi:https://doi.org/10.1158/1078-0432.CCR-18-0483
- Wu G, Xue M, Zhao Y, Han Y, Zhang S, Zhang J, Li C, Yu J et al. Low circulating 25-hydroxyvitamin D level is associated with increased colorectal cancer mortality: a systematic review and dose-response meta-analysis. Biosci Rep. 2020;40(7).
- Ben Fradj MK, Bibi M, Hammami MB, Kallel A, Nouira Y, Feki M. Low plasma 25-hydoxyvitamin D at diagnosis predicts poor outcomes in patients with bladder cancer: a prospective cohort study. Nutr Cancer2020 Jul 16;1-7.
- Negri M, Gentile A, de Angelis C, Montò T, Patalano R, Colao A, Pivonello R, Pivonello C. Vitamin D-induced molecular mechanisms to potentiate cancer therapy and to reverse drug-resistance in cancer cells. Nutrients. 2020;12(6):1798. doi:https://doi.org/10.3390/nu12061798
- Manson JE, Cook NR, Lee I-M, Christen W, Bassuk SS, Mora S, Gibson H, Gordon D, Copeland T, D'Agostino D, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019;380(1):33–44. doi:https://doi.org/10.1056/NEJMoa1809944
- Keum N, Lee DH, Greenwood DC, Manson JE, Giovannucci E. Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials. Ann Oncol. 2019;30(5):733–743. doi:https://doi.org/10.1093/annonc/mdz059
- Heaney RP. Guidelines for optimizing design and analysis of clinical studies of nutrient effects. Nutr Rev. 2014;72(1):48–54. doi:https://doi.org/10.1111/nure.12090
- McDonnell SL, Baggerly CA, French CB, Baggerly LL, Garland CF, Gorham ED, et al. Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations ≥60 vs <20 ng/ml (150 vs 50 nmol/L): pooled analysis of two randomized trials and a prospective cohort. PLoS One. 2018;13(6):e0199265-e.
- McDonnell SL, Baggerly C, French CB, Baggerly LL, Garland CF, Gorham ED, Lappe JM, Heaney RP. Serum 25-hydroxyvitamin d concentrations ≥40 ng/ml are associated with >65% lower cancer risk: pooled analysis of randomized trial and prospective cohort study. PLoS One. 2016;11(4):e0152441. doi:https://doi.org/10.1371/journal.pone.0152441
- Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011;96(1):53–58. doi:https://doi.org/10.1210/jc.2010-2704
- Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930. doi:https://doi.org/10.1210/jc.2011-0385
- Sonawane KB, Cheng N, Hansen RA. Serious adverse drug events reported to the FDA: analysis of the FDA Adverse Event Reporting System 2006-2014 Database. JMCP. 2018;24(7):682–690. doi:https://doi.org/10.18553/jmcp.2018.24.7.682
- Harvie M. Nutritional supplements and cancer: potential benefits and proven harms. Am Soc Clin Oncol Educ Book. 2014;(34):e478–86–e486. doi:https://doi.org/10.14694/EdBook_AM.2014.34.e478